Science News
from research organizations

Up to 2 per cent of Germany's population is dependent on hypnotics

Date:
January 28, 2015
Source:
Deutsches Aerzteblatt International
Summary:
Every year, the statutory health insurance companies cover bills for some 230 million daily doses of benzodiazepines. Roughly the same amount again is prescribed in private prescriptions, but this figure is often not taken into consideration. The exact number of persons with benzodiazepine dependency is not known, but an estimated 128,000 to 1.6 million people in Germany are likely to be affected.
Share:
FULL STORY

Every year, the statutory health insurance companies cover bills for some 230 million daily doses of benzodiazepines. Roughly the same amount again is prescribed in private prescriptions, but this figure is often not taken into consideration. The exact number of persons with benzodiazepine dependency is not known, but an estimated 128,000 to 1.6 million people in Germany are likely to be affected. Katrin Janhsen et al. show in their current review article in Deutsches Ärzteblatt International what is behind the high prescription volume of benzodiazepines and what needs to be considered for the purposes of withdrawal treatment.

Benzodiazepines are important substances, and emergency medicine, anesthesiology, and psychiatric emergencies are as good as unimaginable without them. However, they are more commonly used as hypnotics and tranquillizers -- for example, in the form of the classic drug valium. One in every two persons taking this medication takes it for insomnia and one in four for restlessness, nervousness, or states of agitation or tension. Benzodiazepines are highly effective, but they are also known to be associated with a high risk of misuse and dependency. The current Medicinal Products Directive (Arzneimittelrichtlinie) stipulates a usual prescription period of up to four weeks. The tablets actually sold, however, in many cases indicate long-term use. If it is necessary for a person with benzodiazepine dependency to undergo withdrawal treatment, the therapy will have to be long term. Persons with pronounced drug dependency will even have to be treated as inpatients, as the authors show on the basis of a flow diagram. They stress that doctors should avoid inappropriate long-term prescribing and should receive more intensive continuing medical education relating to the prevention and treatment of medication dependency.


Story Source:

Materials provided by Deutsches Aerzteblatt International. Note: Content may be edited for style and length.


Journal Reference:

  1. Janhsen K, Roser P, Hoffmann K. The problems of long-term treatment with benzodiazepines and related substances—prescribing practice, epidemiology and the treatment of withdrawal. Dtsch Arztebl Int, January 2015 DOI: 10.3238/arztebl.2015.0001

Cite This Page:

Deutsches Aerzteblatt International. "Up to 2 per cent of Germany's population is dependent on hypnotics." ScienceDaily. ScienceDaily, 28 January 2015. <www.sciencedaily.com/releases/2015/01/150128082011.htm>.
Deutsches Aerzteblatt International. (2015, January 28). Up to 2 per cent of Germany's population is dependent on hypnotics. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/01/150128082011.htm
Deutsches Aerzteblatt International. "Up to 2 per cent of Germany's population is dependent on hypnotics." ScienceDaily. www.sciencedaily.com/releases/2015/01/150128082011.htm (accessed May 23, 2017).

RELATED STORIES